Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease
Completed
- Conditions
- Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical Treatment
- Registration Number
- NCT02887287
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
The study aimed to prove EEN is effective for inducing early clinical remission, mucosal healing, promoting fistula closure and reducing the size of abscess to adult CD patients. They plan to include about 50 patients and observe the effect of EEN.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
- >18 years old
- Patients with CD was diagnosed clinically according to previously established international criteria [9]
- The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation but not fibrosis.
Exclusion Criteria
- Patients do not macth the inclusion criteria and those who refuse to taking part in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical remission after 12 weeks EEN July 2013 to October 2015
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways mediate mucosal healing via EEN in adult Crohn's Disease patients?
How does EEN compare to anti-TNF therapy in inducing remission for complex Crohn's Disease cases?
Which biomarkers correlate with fistula closure and abscess reduction during EEN treatment?
What are the long-term safety profiles and management strategies for EEN in active CD patients?
Are there synergistic effects of combining EEN with immunomodulators in refractory Crohn's Disease?
Trial Locations
- Locations (1)
The six affiliated hospital of Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China
The six affiliated hospital of Sun Yat-sen University🇨🇳Guangzhou, Guangdong, China